Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2022-08-29 to 2028-10-01
Current total value of award: $211409788
Description: THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE CLIN0004B IN THE AMOUNT OF $17,104,200 FOR 40,000 TREATMENT COURSES OF ORAL SUSPENSION TEMBEXA AND UPDATED ARTICLE B.2.2 OPTIONS, TABLE 5.